1,060
Views
1
CrossRef citations to date
0
Altmetric
Hematology

Impact of Sickle Cell Disease on Affected Individuals in Nigeria: A Critical Review

ORCID Icon, ORCID Icon & ORCID Icon
Pages 3503-3515 | Received 24 Feb 2023, Accepted 08 Jun 2023, Published online: 14 Aug 2023

References

  • Onyemaechi NO, Enweani UN, Maduka CO. Musculoskeletal complications of sickle cell disease in Enugu, Nigeria. Niger J Med. 2011;20(4):456–461.
  • Onoja SO, Eluke BC, Dangana A, Musa S, Abdullahi IN. Evaluation of von Willebrand factor and other coagulation homeostasis profile of patients with sickle cell anaemia attending a tertiary hospital at Enugu, Nigeria. Med J Zambia. 2020;47(4):269–275. doi:10.55320/mjz.47.4.715
  • Abdullahi SU, DeBaun MR, Jordan LC, Galadanci NA. Increased prevalence of stroke recurrence and stroke related mortality in children with sickle cell disease in Nigeria: evidence for a secondary stroke prevention trial. Pediatr Neurol. 2019;95:73–78. doi:10.1016/j.pediatrneurol.2019.01.008
  • Smith OS, Ajose OA, Adegoke SA, Adegoke OA, Adedeji TA, Oderinu KA. Plasma level of antioxidants is related to frequency of vaso-occlusive crises in children with sickle cell anaemia in steady state in Nigeria. Pediatr Hematol Oncol J. 2019;4(1):17–22. doi:10.1016/j.phoj.2019.03.003
  • Oladipo OO, Temiye EO, Ezeaka VC, Obomanu P. Serum magnesium, phosphate and calcium in Nigerian children with sickle cell disease. West Afr J Med. 2005;24(2):120–123. doi:10.4314/wajm.v24i2.28180
  • Maigatari DM, Abdulrasheed I, Lawal DI, Hassan A, Augustine B, Muhammad PK. Preoperative blood transfusion in adults with sickle cell disease undergoing elective surgical procedures: a survey of practice and outcome in Zaria, Nigeria. Arch Int Surg. 2017;7:17–21. doi:10.4103/ais.ais_45_17
  • Taiwo IA, Oloyede OA, Dosumu AO. Frequency of sickle cell genotype among the Yorubas in Lagos: implications for the level of awareness and genetic counseling for sickle cell disease in Nigeria. J Community Genet. 2011;2:13–18. doi:10.1007/s12687-010-0033-x
  • Bukar AA, Sulaiman MM, Ladu AI, et al. Chronic kidney disease amongst sickle cell anaemia patients at the university of Maiduguri teaching hospital, northeastern Nigeria: a study of prevalence and risk factors. Mediterr J Hematol Infect Dis. 2019;11(1):e2019010. doi:10.4084/MJHID.2019.010
  • Nwabuko OC, Okoh DA, Iyalla C, Omunakwe H. Prevalence of sickle cell disease among pregnant women in a tertiary health center in south-south Nigeria. Sub Saharan Afr J Med. 2016;3:132–136. doi:10.4103/2384-5147.190843
  • Aygun B, Odame I. A global perspective on sickle cell disease. Pediatr Blood Cancer. 2012;59:386–390. doi:10.1002/pbc.24175
  • Stephen N, Nden N, Gusen NJ, Kumzhi PR, Gaknung B, Auta DA. Prevalence of sickle cell disease among children attending plateau specialist hospital, Jos, Nigeria. Acta Med Int. 2018;5:20–23. doi:10.4103/ami.ami_60_17
  • Nwongoh B, Adewoyin AS, Iheanacho OE, Bazuaye GN. Prevalence of haemoglobin variants in Benin City, Nigeria. Ann Biomed Sci. 2012;2(2):60–64.
  • Oguanobi NI, Onwubere BJ, Ibegbulam OG, et al. Arterial blood pressure in adult Nigerians with sickle cell anemia. J Cardiol. 2010;56:326–331. doi:10.1016/j.jjcc.2010.07.001
  • Juwah AI, Nlemadim EU, Kaine W. Types of anaemic crises in paediatric patients with sickle cell anaemia seen in Enugu, Nigeria. Arch Dis Child. 2014;89:572–576. doi:10.1136/adc.2003.037374
  • Sokunbi OJ, Ekure EN, Temiye EO, Anyanwu R, Okoromah CAN. Pulmonary hypertension among 5 to 18 year old children with sickle cell anaemia in Nigeria. PLoS One. 2017;12(9):e0184287. doi:10.1371/journal.pone.0184287
  • Ozoh OB, Kalejaiye OO, Eromesele OE, Adelabu YA, Dede SK, Ogunlesi FO. Pulmonary dysfunction among adolescents and adults with sickle cell disease in Nigeria: implications for monitoring. Ann Thorac Med. 2019;14(4):269–277. doi:10.4103/atm.ATM_58_19
  • VanderJagt DJ, Trujillo MR, Jalo I, Bode-Thomas F, Glew RH, Agabac P. Pulmonary function correlates with body composition in Nigerian children and young adults with sickle cell disease. J Pediatr. 2007;54(2):87–93. doi:10.1093/tropej/fmm070
  • Adebiyi AA, Oyebowale OM, Olaniyi AJ, Falase AO. Heart rate variability study in adult Nigerian subjects with sickle cell disease during vaso-occlusive crisis. Niger Postgrad Med J. 2019;6:8–12. doi:10.4103/npmj.npmj_186_18
  • Oguanobi NI, Onwubere BJ, Ike SO, Anisiuba BC, Ejim EC, Ibegbulam OG. Electocardiographic findings in adult Nigerians with sickle cell anaemia. Afr Health Sci. 2010;10(3):235–241.
  • Dosunmu A, Akinbami A, Uche E, Adediran A, John-Olabode S. Electrocardiographic Study in adult homozygous sickle cell disease patients in Lagos, Nigeria. J Trop Med. 2016;2016:1–5. doi:10.1155/2016/4214387
  • Akingbola TS, Kolude B, Aneni EC, et al. Abdominal pain in adult sickle cell disease patients: a Nigerian Experience. Ann Ibd Pg Med. 2011;9(2):100–104.
  • Jebbin NJ, Adotey JM. Acute abdominal conditions in people with sickle cell disease: a 10-year experience in PortHarcourt, Nigeria. Ann Afr Med. 2011;10:165–170. doi:10.4103/1596-3519.82072
  • Brown BJ, Jacob NE, Lagunju IA, Jarrett OO. Morbidity and mortality pattern in hospitalized children with sickle cell disorders at the University College Hospital, Ibadan, Nigeria. Niger J Paed. 2013;40(1):34–39. doi:10.4314/njp.v40i1.6
  • Bello N, Dawakin Kudu AT, Adetokun AB, et al. Characterization and antimicrobial susceptibility profile of bacteraemia causing pathogens isolated from febrile children with and without sickle cell disease in Kano, Nigeria. Mediterr J Hematol Infect Dis. 2018;10(1):e2018016. doi:10.4084/MJHID.2018.016
  • Afolabi BB, Iwuala NC, Iwuala IC, Ogedengbe OK. Morbidity and mortality in sickle cell pregnancies in Lagos, Nigeria: a case control study. J Obstet Gynaecol. 2009;29(2):104–106. doi:10.1080/01443610802667112
  • Ugboma HA, George IO. Sickle cell disease in pregnancy: maternal and fetal outcome in Port Harcourt, Nigeria. Br J Med Med Res. 2015;7(1):40–44. doi:10.9734/BJMMR/2015/11602
  • Ocheni S, Onah HE, Ibegbulam OG, Eze MI. Pregnancy outcomes in patients with sickle cell disease in Enugu, Nigeria. Niger J Med. 2007;16(3):227–230.
  • Diwe K, Iwu AC, Uwakwe K, et al. Prevalence and patterns of sickle cell disease among children attending tertiary and non-tertiary health care institutions in a South Eastern State, Nigeria: a 10 year survey. J Res Med Dent Sci. 2016;4(3):75–81. doi:10.5455/jrmds.2016432
  • Kingsley A, Enang O, Essien O, Legogie A, Cletus O, Oshatuy O. Prevalence of sickle cell disease and other haemoglobin variants in Calabar, Cross River State, Nigeria. Annu Res Rev Biol. 2019;13:1–6. doi:10.9734/ARRB/2019/v33i530132
  • Salawu L, Orimolade EA, Durosinmi MA. Immuno-haematological characteristics of Nigerian sickle cell disease patients in asymptomatic steady state. Eur J Gen Med. 2009;6(3):170–174.
  • Akinbami A, Dosunmu A, Adediran A, Oshinaike O, Adebola P, Arogundadeet O. Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria. BMC Res Notes. 2012;5:396. doi:10.1186/1756-0500-5-396
  • Akinbami A, Dosunmu A, Adediran A, et al. Steady state hemoglobin concentration and packed cell volume in homozygous sickle cell disease patients in Lagos, Nigeria. Caspian J Intern Med. 2012;3(2):405–409.
  • Omoti CE. Haematological values in sickle cell anaemia in steady state and during vaso-occlusive crisis in Benin City, Nigeria. Ann Afr Med. 2005;4:62–67.
  • Bot YS, Benjamin A, Nyango DY, et al. Analyses of Cu and Zn in serum of sickle cell disease patients in Jos. Int J Med Sci. 2015;3(3):207–209.
  • Adelakun A, Ajani O, Ogunleye T, Disu E, Kosoko A, Arinola G. Respiratory burst enzymes and oxidant antioxidant status in Nigerian Children with Sickle Cell Disease. Br Biotechnol J. 2014;4(3):270–278. doi:10.9734/BBJ/2014/7411
  • Akinbami AA, Dosunmu AO, Adediran AA, et al. Serum ferritin levels in adults with sickle cell disease in Lagos, Nigeria. J Blood Med. 2013;4:59–63. doi:10.2147/JBM.S42212
  • Odunlade OC, Adeodu OO, Owa JA, Obuotor EM. Iron overload in steady state, non-chronically transfused children with sickle cell anaemia in Ile-Ife, Nigeria. Pediatr Hematol Oncol J. 2017;2(2):35–38. doi:10.1016/j.phoj.2017.08.001
  • Ibe EO, Ezeoke AC, Emeodi I, Akubugwo EI, Elekwa E, Ugonabo MC. Electrolyte profile and prevalent causes of sickle cell crisis in Enugu, Nigeria. Afr J Biochem. 2009;3(11):370–374.
  • Diaku-Akinwumi IN, Abubakar SB, Adegoke SA, et al. Blood transfusion services for patients with sickle cell disease in Nigeria. Int Health. 2016;8(5):330–335. doi:10.1093/inthealth/ihw014
  • Ubesie AC, Emodi IJ, Ikefuna AN, Ilechukwu GC, Ilechukwu G. Prevalence of human immunodeficiency virus transmission among transfused children with sickle cell anemia in Enugu Nigeria. Ann Med Health Sci Res. 2012;2:109–113. doi:10.4103/2141-9248.105655
  • Fasola FA, Otegbayo IA. Post transfusion viral hepatitis in sickle cell anemia: retrospective-prospective analysis. Niger J Clin Pract. 2002;5(1):16–19.
  • Ejiofor OS, Ibe BC, Emodi IJ, et al. The role of blood transfusion on the prevalence of hepatitis c virus antibodies in children with sickle cell anemia in Enugu, south east Nigeria. Niger J Clin Pract. 2009;12(4):355–358.
  • Nwannadi IA, Alao OO, Bazuaye GN, Omoti CE, Hali NK. Seroprevalence of hepatitis c virus antibody in sickle cell anaemia patients in Benin-city, Nigeria. GJMS. 2012;10(1):2.
  • Babatola AO, Olatunya OS, Faboya AO, et al. Hepatitis B and C infections among pediatric patients with sickle cell disease at a tertiary hospital in Nigeria. Arch Pediatr Infect Dis. 2020;8(4):e101632. doi:10.5812/pedinfect.101632
  • Bolarinwa RA, Aneke JC, Olowookere SA, Salawu L. Seroprevalence of transfusion transmissible viral markers in sickle cell disease patients and healthy controls in Ile-Ife, SouthWestern Nigeria: a case–control study. J Appl Hematol. 2015;6(4):162–167. doi:10.4103/1658-5127.171985
  • Ugwu NI, Awodu OA, Bazuaye GN, Okoye AE. Red cell alloimmunization in multi- transfused patients with sickle cell anemia in Benin City, Nigeria. Niger J Clin Pract. 2015;18:522–526. doi:10.4103/1119-3077.154204
  • Kangiwa U, Ibegbulam O, Ocheni S, Madu A, Mohammed N. Pattern and prevelence of alloimmunization in multiply transfused patients with sickle cell disease in Nigeria. J Blood Med. 2015;3(1):59–63. doi:10.2147/JBM.S42212
  • Ojelabi AO, Bamgboye AE, Ling J. Preference-based measure of health-related quality of life and its determinants in sickle cell disease in Nigeria. PLoS One. 2019;4(11):e0223043. doi:10.1371/journal.pone.0223043
  • Tunde-Ayinmode MF. Children with sickle cell disease who are experiencing psychosocial problems concurrently with their mothers: a Nigerian study. Afr J Psychiatry. 2011;14:392–401. doi:10.4314/ajpsy.v14i5.8
  • Aloba O, Eyiolawi D. Correlates of hopelessness in clinically stable Nigerian adults with sickle cell disease. Niger J Clin Pract. 2020;23:219–225. doi:10.4103/njcp.njc_119_19
  • Ohaeri JU, Shokunbi WA. Psychosocial burden of sickle cell disease on caregivers in a Nigerian setting. J Natl Med Assoc. 2002;94(12):1058–1070.
  • Adegoke SA, Kuteyi EA. Psychosocial burden of sickle cell disease on the family, Nigeria. Afr J Prm Health Care Fam Med. 2012;4(1). doi:10.4102/phcfm.v4i1.380
  • Nwadiaro HC, Ugwu BT, Legbo JN. Chronic osteomyelitis in patients with sickle cell disease. East Afr Med J. 2000;77(1):23–26. doi:10.4314/eamj.v77i1.46370
  • Ebong WA. Acute osteomyelitis in Nigerians with sickle cell disease. Ann Rheum Dis. 1986;45:911–915. doi:10.1136/ard.45.11.911
  • Akinyoola AL, Adediran IA, Asaleye CM, Bolarinw AR. Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease. Int Orthop. 2009;33:923–926. doi:10.1007/s00264-008-0584-1
  • Iwegbu CG, Fleming AF. Avascular necrosis of the femoral head in sickle cell disease. A series from the Guinea Savannah of Nigeria. J Bone Joint Surg. 1985;67(1):29–33. doi:10.1302/0301-620X.67B1.3968138
  • Balogun RA, Obalum DC, Giwa SO, Adekoya-Cole TO, Ogo CN, Enweluzo GO. Spectrum of musculo-skeletal disorders in sickle cell disease in Lagos, Nigeria. J Orthop Surg Res. 2010;5:1–6. doi:10.1186/1749-799X-5-2
  • Buseri FI, Jeremiah ZA, Shokunbi WA. Plasma levels ofsome blood coagulationparameters in Nigerian homozygous sickle cell patients (HbSS) in steady state. Hematology. 2006;11(5–6):375–379. doi:10.1080/10245330600841287
  • Kotila R, Okesola A, Makanjuola O. Asymptomatic malaria parasitaemia in sickle-cell disease patients: how effective is chemoprophylaxis? J Vect Borne Dis. 2007;44:52–55.
  • Okocha CE, Manafa PO, Ozomba JO, Ulasi TO, Chukwuma GO, Aneke JC. C‑reactive protein and disease outcome in Nigerian sickle cell disease patients. Ann Med Health Sci Res. 2014;4(5):701–705. doi:10.4103/2141-9248.141523
  • Fakunle EE, Eteng KI, Shokunb WA. D-D dimer levels in patients with sickle cell disease during bone pain crises and in the steady state. PLMI. 2012;4:21–25. doi:10.2147/PLMI.S29393
  • Abudu EK, Akanmu SA, Soriyan OO, et al. Serum testosterone levels of HbSS (sickle cell disease) male subjects in Lagos, Nigeria. BMC Res Notes. 2011;4:298. doi:10.1186/1756-0500-4-298
  • Akinbami AA, Ajibola S, Bode-Shojobi I, et al. Prevalence of significant bacteriuria among symptomatic and asymptomatic homozygous sickle cell disease patients in a tertiary hospital in Lagos, Nigeria. Niger J Clin Pract. 2014;17:163–167. doi:10.4103/1119-3077.127441
  • Adeniyi AF, Saminu KS. Non communicable diseases local incentive spirometry improves peak expiratory flow rate in teenage sickle cell anaemia patients: a randomized pilot trial. Afr Health Sci. 2011;11(3):303–308.
  • Oniyangi O, Ahmed P, Otuneye OT, et al. Strokes in children with sickle cell disease at the National Hospital Abuja Nigeria. Niger J Paed. 2013;40(2):158–164. doi:10.4314/njp.v40i2.10
  • Adediran A, Wright K, Akinbami A, Dosunmu A, Oshinaike O, Osikomaiya B. Prevalence of priapism and its awareness amongst male homozygous sickle cell patients in Lagos, Nigeria. Adv Urol. 2013;2013:1–4. doi:10.1155/2013/890328
  • Hassan A, Gayus DL, Abdulrasheed I, Umar MA, Ismail DL, Babadoko AA. Chronic leg ulcers in sickle cell disease patients in Zaria, Nigeria. Arch Int Surg. 2014;4:141–145. doi:10.4103/2278-9596.146405
  • Bazuaye GN, Nwannadi AI, Olayemi EE. Leg ulcers in adult sickle cell disease patients in Benin City Nigeria. GJMS. 2010;8(2):190–194.
  • Adegoke SA, Smith OS, Akinlosotu MA. Total oxidant status of children with sicklecell anaemia: correlation with rate of pain episodes and haematological indices. Pediatr Hematol Oncol J. 2018;3(3):70–73. doi:10.1016/j.phoj.2018.10.002
  • Iliyasu Z, Borodo AM, Jibir BW, Nass NS, Aliyu MH. “A child with sickle cell disease can’t live with just anyone.” A mixed methods study of socio-behavioral influences and severity of sickle cell disease in northern Nigeria. Health Sci Rep. 2020;4:e222. doi:10.1002/hsr2.222
  • Uchendu UO, Ikefuna AN, Nwokocha AR, Emodi IJ. Impact of socioeconomic status on sexual maturation of Nigerian boys living with sickle cell anaemia. Hematolog. 2010;15(6):414–421. doi:10.1179/102453310X12647083621209
  • Olatunya OS, Babatola AO, Adeniyi AT, et al. Determinants of care-seeking practices for children with sickle cell disease in Ekiti, Southwest Nigeria. J Blood Med. 2021;2:123–132. doi:10.2147/JBM.S294952
  • Adegboyega LO. Psycho-social problems of adolescents with sickle-cell anaemia in Ekiti State, Nigeria. Afr Health Sci. 2021;21(2):775–781. doi:10.4314/ahs.v21i2.37
  • Nwagha T, Omotowo BI. Determinants of psychosocial health‑related quality of life of adults with sickle cell disease in a Nigerian setting. Niger Med J. 2020;61:114–119. doi:10.4103/nmj.NMJ_122_19
  • Ayoola OO, Bolarinwa RA, Onakpoya UU, Adedeji TA, Onwuka CC, Idowu BM. Intima-media thickness of the common femoral artery as a marker of leg ulceration in sickle cell disease patients. Blood Adv. 2018;2(22):3112–3117. doi:10.1182/bloodadvances.2018023267
  • Okafor LA, Nonnoo DC, Ojehanon PI, Aikhionbare O. Oral and dental complications of sickle cell disease in Nigerians. Angiology. 1986;37(9):672–675. doi:10.1177/000331978603700909
  • Alabi S, Ernest K, Eletta P, Owolabi A, Afolabi A, Suleiman O. Otological findings among Nigerian children with sickle cell anaemia. Int J Pediatr Otorhinolaryngol. 2008;72(5):659–663. doi:10.1016/j.ijporl.2008.01.024
  • Agholor CA, Akhigbe AO, Atalabi OM. The prevalence of cholelithiasis in Nigerians with sickle cell disease as diagnosed by ultrasound. Br J Med Med Res. 2014;4(15):2866. doi:10.9734/BJMMR/2014/8645
  • Olaniyi JA, Abjah UM. Frequency of hepatomegaly and splenomegaly in Nigerian patients with sickle cell disease. West Afr J Med. 2007;26(4):274–277. doi:10.4314/wajm.v26i4.28326
  • Brown BJ, Fatunde OJ, Sodeinde O. Correlates of steady-state haematocrit and hepatosplenomegaly in children with sickle cell disease in Western Nigeria. West Afr J Med. 2012;31(2):86–91.
  • Odunvbun ME, Adeyekun AA. Ultrasonic assessment of the prevalence of gall stones in sickle cell disease children seen at the University of Benin Teaching Hospital, Benin City, Nigeria. Niger J Paediatr. 2014;41(4):370–374. doi:10.4314/njp.v41i4.16
  • Eze CU, Offordile GC, Agwuna KK, Ocheni S, Nwadike IU, Chukwu BF. Sonographic evaluation of the spleen among sickle cell disease patients in a teaching hospital in Nigeria. Afr Health Sci. 2015;15(3):949–958. doi:10.4314/ahs.v15i3.32
  • VanderJagt DJ, Okolo SN, Rabasa AI, Glew RH. Bioelectrical impedance analysis of the body composition of Nigerian children with sickle cell disease. J Trop Pediatr. 2000;46(2):67–72. doi:10.1093/tropej/46.2.67
  • Dosunmu AO, Akinola RA, Onakoya JA, et al. Pattern of chronic lung lesions in adults with sickle cell disease in Lagos, Nigeria. Caspian J Intern Med. 2013;4(4):754.
  • Luntsi G, Eze CU, Ahmadu MS, Bukar AA, Ochie K. Sonographic evaluation of some abdominal organs in sickle cell disease patients in a tertiary health institution in Northeastern Nigeria. J Med Ultrasound. 2018;26(1):31. doi:10.4103/JMU.JMU_5_17
  • Madu AJ, Okoye AE, Ajuba IC, Madu KA, Anigbo C, Agu K. Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South‑Eastern Nigeria. Niger J Clin Pract. 2016;19(4):471–474. doi:10.4103/1119-3077.183299
  • Babadoko AA, Ibinaye PO, Hassan A, et al. Autosplenectomy of sickle cell disease in Zaria, Nigeria: an ultrasonographic assessment. Oman Med J. 2012;27(2):121. doi:10.5001/omj.2012.25
  • Oredugba FA, Savage KO. Anthropometric findings in Nigerian children with sickle cell disease. Pediatr Dent. 2002;24(4):321–325.
  • Arinola OG, Olaniyi JA, Akiibinu MO. Evaluation of antioxidant levels and trace element status in Nigerian sickle cell disease patients with Plasmodium parasitaemia. Pak J Nutr. 2008;7(6):766–769. doi:10.3923/pjn.2008.766.769
  • Nnodin JK, Opara AU, Nwanjo HU, Ibeaja OA. Plasma lipid profile in sickle cell disease patients in Owerri, Nigeria. Pak J Nutr. 2012;11(1):64–65. doi:10.3923/pjn.2012.64.65
  • Iheanacho O. Haematological parameters of adult and paediatric subjects with sickle cell disease in steady state, in Benin City, Nigeria. Int Blood Res Rev. 2015;3(4):171–177. doi:10.9734/IBRR/2015/18339
  • Olaniyi JA, Arinola OG, Odetunde AB. Foetal haemoglobin (HbF) status in adult sickle cell anaemia patients in Ibadan, Nigeria. Ann Ib Postgrad Med. 2010;8(1):30–33. doi:10.4314/aipm.v8i1.63955
  • Olorunshola KV, Audu L. ABO (H) secretor status of sickle cell disease patients in Zaria, Kaduna State, Nigeria. Niger J Physiol Sci. 2013;28(1):29–34.
  • Brown BJ, Okereke JO, Lagunju IA, Orimadegun AE, Ohaeri JU, Akinyinka OO. Burden of health‐care of carers of children with sickle cell disease in Nigeria. Health Soc Care Community. 2010;18(3):289–295.
  • Aneke JC, Adegoke AO, Oyekunle AA, et al. Degrees of kidney disease in Nigerian adults with sickle-cell disease. Med Princ Pract. 2014;23(3):271–274. doi:10.1159/000361029
  • VanderJagt DJ, Shores J, Okorodudu A, Okolo SN, Glew RH. Hypocholesterolemia in Nigerian children with sickle cell disease. J Trop Pediatr. 2002;48(3):156–161. doi:10.1093/tropej/48.3.156
  • Kotila T, Adedapo K, Adedapo A, Oluwasola O, Fakunle E, Brown B. Liver dysfunction in steady state sickle cell disease. Ann Hepatol. 2005;4(4):261–263. doi:10.1016/S1665-2681(19)32049-6
  • Isah IZ, Udomah FP, Erhabor O, et al. Foetal haemoglobin levels in sickle cell disease (SCD) patients in Sokoto, Nigeria. Br J Med Health Sci. 2013;1(6):36–47.
  • Ukoha OM, Emodi IJ, Ikefuna AN, Obidike EO, Izuka MO, Eke CB. Comparative study of nutritional status of children and adolescents with sickle cell anemia in Enugu, Southeast Nigeria. Niger J Clin Pract. 2020;23(8):1079–1086. doi:10.4103/njcp.njcp_476_19
  • VanderJagt DJ, Trujillo MR, Bode-Thomas F, Huang YS, Chuang LT, Glew RH. Phase angle correlates with n-3 fatty acids and cholesterol in red cells of Nigerian children with sickle cell disease. Lipids Health Dis. 2003;2:1–8. doi:10.1186/1476-511X-2-2
  • Idris IM, Abba A, Galadanci JA, et al. Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease. Blood Adv. 2020;4(14):3277–3283. doi:10.1182/bloodadvances.2020002062
  • Ikefuna AN, Emodi IJ, Ocheni S. Clinical profile and home management of sickle cell-related pain: the Enugu (Nigeria) experience. Pediatr Hematol Oncol. 2009;26(5):309–312. doi:10.1080/08880010902754818
  • Madu AJ, Galadanci NA, Nalado AM, et al. Stroke prevalence amongst sickle cell disease patients in Nigeria: a multi-centre study. Afr Health Sci. 2014;14(2):446–452. doi:10.4314/ahs.v14i2.22
  • Dosunmu AO, Balogun TM, Adeyeye OO, et al. Prevalence of pulmonary hypertension in sickle cell anaemia patients of a tertiary hospital in Nigeria. Niger J Med. 2014;55(2):161. doi:10.4103/0300-1652.129661
  • Adeyemo T, Ojewunmi O, Oyetunji A. Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria. Pan Afr Med J. 2014;18. doi:10.11604/pamj.2014.18.71.4239
  • Akubuilo UC, Ayuk A, Ezenwosu OU, Okafor UH, Emodi IJ. Persistent hematuria among children with sickle cell anemia in steady state. Hematol Transfus Cell Ther. 2020;42:255–260. doi:10.1016/j.htct.2019.07.007
  • Lagunju I, Sodeinde O, Telfer P. Prevalence of transcranial Doppler abnormalities in Nigerian children with sickle cell disease. Am J Hematol. 2012;87(5):544–547. doi:10.1002/ajh.23152
  • Bolarinwa RA, Akinlade KS, Kuti MA, Olawale OO, Akinola NO. Renal disease in adult Nigerians with sickle cell anemia: a report of prevalence, clinical features and risk factors. Saudi J Kidney Dis Transpl. 2012;23(1):171–175.
  • Nnaji GA, Ezeagwuna DA, Nnaji IJ, Osakwe JO, Nwigwe AC, Onwurah OW. Prevalence and pattern of sickle cell disease in premarital couples in Southeastern Nigeria. Niger J Clin Pract. 2013;16(3):309–314. doi:10.4103/1119-3077.113452
  • Adegoke SA, Adeodu OO, Adekile AD. Sickle cell disease clinical phenotypes in children from South. Western, Nigeria. Niger J Clin Pract. 2015;18(1):95–101. doi:10.4103/1119-3077.146987
  • Duru A, Madu AJ, Okoye H, et al. Variations and characteristics of the various clinical phenotypes in a cohort of Nigerian sickle cell patients. Hematology. 2021;26(1):684–690. doi:10.1080/16078454.2021.1972242
  • Saganuwan SA. The pattern of sickle cell disease in sickle cell patients from Northwestern Nigeria. Therapeutics. 2016;8:CMT–S38164.
  • Isa H, Adegoke S, Madu A, et al. Sickle cell disease clinical phenotypes in Nigeria: a preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database. Blood Cells Mol Dis. 2020;84:102438. doi:10.1016/j.bcmd.2020.102438
  • Anie KA, Egunjobi FE, Akinyanju OO. Psychosocial impact of sickle cell disorder: perspectives from a Nigerian setting. Global Health. 2010;6:1–6. doi:10.1186/1744-8603-6-2
  • Ola B, Coker R, Ani C. Stigmatising attitudes towards peers with sickle cell disease among secondary school students in Nigeria. Int J Child Fam Stud. 2013;4(4):391–402. doi:10.18357/ijcyfs44201312693
  • Adeyemo TA, Ojewunmi OO, Diaku‐Akinwumi IN, Ayinde OC, Akanmu AS. Health related quality of life and perception of stigmatisation in adolescents living with sickle cell disease in Nigeria: a cross sectional study. Pediatr Blood Cancer. 2015;62(7):1245–1251. doi:10.1002/pbc.25503
  • Adewoyin S. Erythrocyte transfusion and alloimmunisation patterns among sickle cell disease patients, Benin City, Nigeria. Br J Med Med Res. 2016;11(10):1–8. doi:10.9734/BJMMR/2016/21755
  • Emokpae A, Kuliya-Gwarzo A. The association of transfusion status with antioxidant enzymes and malondialdehyde level in Nigerians with sickle cell disease. Asian J Transfus Sci. 2014;8(1):47. doi:10.4103/0973-6247.126692
  • Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–2031. doi:10.1016/S0140-6736(10)61029-X
  • Bebe T, Odetoyin B, Bolarinwa R. Occurrence of multidrug-resistant uropathogens implicated in asymptomatic bacteriuria in adults with sickle cell disease in ile-ife, Southwest Nigeria. Oman Med J. 2020;35(2):e109. doi:10.5001/omj.2020.27
  • Adewoyin AS, Oyewale OA. Complications of allogeneic blood transfusion: current approach to diagnosis and management. Int Blood Res Rev. 2015;3(4):135–151. doi:10.9734/IBRR/2015/17874
  • Adekile AD, Gupta R, Yacoub F, Sinan T, Al-Bloushi M, Haider MZ. Avascular necrosis of the Hip in children with sickle cell disease and the high Hb F: magnetic resonance imaging findings and influence of alpha-thalassemia trait. Acta Haematol. 2001;105(1):27–31. doi:10.1159/000046529
  • Weeraratne S. Theorizing the expansion of the Boko Haram insurgency in Nigeria. Terror Polit Violenc. 2017;29(4):610–634. doi:10.1080/09546553.2015.1005742
  • Dunn G. The impact of the Boko Haram insurgency in Northeast Nigeria on childhood wasting: a double-difference study. Confl Health. 2018;12(1):1–2. doi:10.1186/s13031-018-0136-2
  • Williams R. The epistemology of knowledge and the knowledge process cycle: beyond the “objectivist” vs “interpretivist”. J Knowl Manag. 2008;12(4):72–85. doi:10.1108/13673270810884264
  • Ikemefuna AN, Emodi IJ. Hospital admission of patients with sickle cell anemia pattern and outcome in Enugu area of Nigeria. Niger J Clin Pract. 2007;10(1):24–29.
  • Ambe JP, Mava Y, Chama R, Farouq G, Machoko Y. Clinical features of sickle cell Anaemia in Northern Nigerian children. WAJM. 2012;31(2):81–85.
  • Federal Ministry of Health. National guideline for the control and management of sickle cell disease; 2014. Available from: http://scsn.com.ng/wp-content/uploads/2014/11/National-Guideline-for-The-Control-and-Management-of-Sickle-Cell-Disease.pdf. Accessed May 26, 2023.
  • Adigwe OP. Access to healthcare for people with sickle cell disease: views of healthcare professionals on policies and practices. Mol Genet Genomic Med. 2023;11(2):e2142. doi:10.1002/mgg3.2142
  • Galadanci N, Wudil BJ, Balogun TM, et al. Current sickle cell disease management practices in Nigeria. Int Health. 2014;6(1):23–28. doi:10.1093/inthealth/iht022
  • Adigwe OP, Onavbavba G, Onoja SO. Attitudes and practices of unmarried adults towards sickle cell disease: emergent factors from a cross sectional study in Nigeria’s capital. Hematology. 2022;27(1):488–493. doi:10.1080/16078454.2022.2059629
  • Adigwe OP. Knowledge and awareness of sickle cell disease: a cross sectional study amongst unmarried adults in Nigeria’s capital city. J Community Genet. 2022;13(6):579–585. doi:10.1007/s12687-022-00607-x